Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
The company is assessing the situation and simultaneously undertaking all the requisite action
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
The new ECO grade is made using renewable feedstock
Subscribe To Our Newsletter & Stay Updated
